But wait, there's more:
"Mar 08 2024 – Broker Rating Changes
POLYNOVO LIMITED ((PNV)) Upgrade to Overweight from Market Weight by Wilsons
Wilsons upgrades its rating for PolyNovo to Overweight from Market Weight and raises its target to $2.44 from $1.79 following a 19% revenue beat in the 1H.
The broker feels the company's position within the US surgeon base has been solidified, particularly for large, difficult to treat burns.
In a rare feat relative to med-tech peers, note the analysts, PolyNovo's expansion outside of the US has progressed to the extent 25% of revenue is now derived from rest-of-the-world (ROW) markets. At the same time, gross margins have held at 95%." LINK
PNV Media Thread, page-3074
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.05 |
Change
-0.020(0.97%) |
Mkt cap ! $1.428B | |||
| Open | High | Low | Value | Volume |
| $2.04 | $2.07 | $2.04 | $194.2K | 94.84K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 9 | 11154 | $2.05 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.06 | 7099 | 9 |
View Market Depth
| Last trade - 10.21am 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
$2.05 |
Change
-0.020 ( 0.67 %) |
||||
| Open | High | Low | Volume | ||
| $2.06 | $2.06 | $2.05 | 8474 | ||
| Last updated 10.43am 21/05/2024 ? | |||||
| PNV (ASX) Chart |